Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 5 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 12:33 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock, par value $.01 per share | 8,000 | $9.50 | $75,960.00 |
DisclosureSEC source: 0001437749-26-021258 · rdgdoc.xml · nonDerivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,785 Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:03 UTC |
Turner Kathy VDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 17,899 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001437749-26-012561 · rdgdoc.xml · derivative · entry 1 Turner Kathy V · CIK 0001740719 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,899 Underlying: Common Stock · 17,899 shares Expires 2036-04-15 F1 · derivative.exercise_date: The stock option vests as follows: 5,966 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 5,967 shares becoming exercisable on April 15, 2029. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 20:02 UTC |
Tomsche David ScottDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 11,933 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001437749-26-012557 · rdgdoc.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933 Underlying: Common Stock · 11,933 shares Expires 2036-04-15 F1 · derivative.exercise_date: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 19:59 UTC |
Basse Gloria FDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 11,933 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001437749-26-012554 · rdgdoc.xml · derivative · entry 1 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933 Underlying: Common Stock · 11,933 shares Expires 2036-04-15 F1 · derivative.exercise_date: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 19:57 UTC |
Wainman Paul RDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 11,933 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001437749-26-012551 · rdgdoc.xml · derivative · entry 1 Wainman Paul R · CIK 0001603581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933 Underlying: Common Stock · 11,933 shares Expires 2036-04-15 F1 · derivative.exercise_date: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 23:57 UTC |
BRIGHAM MICHAEL FDirector
|
Exercise / conversionStock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.84 | $0.00 |
DisclosureSEC source: 0001437749-26-009661 · rdgdoc.xml · derivative · entry 3 BRIGHAM MICHAEL F · CIK 0001136544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 23:57 UTC |
BRIGHAM MICHAEL FDirector
|
Tax withholdingCommon Stock, par value $.01 per share | 24,052 | $6.07 | $145,995.64 |
DisclosureSEC source: 0001437749-26-009661 · rdgdoc.xml · nonDerivative · entry 2 BRIGHAM MICHAEL F · CIK 0001136544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,700 F2 · shares: Number of shares surrendered to the Issuer in payment of the exercise price of the option. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 23:57 UTC |
BRIGHAM MICHAEL FDirector
|
Exercise / conversionCommon Stock, par value $.01 per share | 25,000 | $5.84 | $146,000.00 |
DisclosureSEC source: 0001437749-26-009661 · rdgdoc.xml · nonDerivative · entry 1 BRIGHAM MICHAEL F · CIK 0001136544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Number of shares resulting from stock-for-stock exercise of stock option. The Reporting Person surrendered previously owned shares in full payment of the exercise price for that option. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 16:43 UTC |
Fiori Timothy CDirector · Chief Financial Officer
|
GrantStock Options (right to buy) · Derivative | 120,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001437749-26-002371 · rdgdoc.xml · derivative · entry 1 Fiori Timothy C · CIK 0002063933 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2036-01-27 F1 · derivative.exercise_date: Option grant made to Mr. Fiori in connection with his employment as Chief Financial Officer. The option shall be treated as an incentive stock option to the maximum extent permitted by the International Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 40,000 options on the first, second and third anniversary of the grant date. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 16:42 UTC |
Brockmann Bobbi JoDirector · VP of Sales and Marketing
|
GrantStock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001437749-26-002369 · rdgdoc.xml · derivative · entry 1 Brockmann Bobbi Jo · CIK 0001517536 · Director · VP of Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-27 F1 · derivative.exercise_date: Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 16:40 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 110,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001437749-26-002366 · rdgdoc.xml · derivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2036-01-27 F1 · derivative.exercise_date: Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year. Read SEC document |
| January 27, 2026 Filed Mar 23, 2026 13:47 UTC Amendment |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 109,500 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001437749-26-009312 · rdgdoc.xml · derivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,500 Underlying: Common Stock · 109,500 shares Expires 2036-01-27 F1 · shares: This amendment amends the previously reported transaction effective on 1/27/2026 to disclose the correct number of shares included in the option award. F2 · derivative.exercise_date: Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year. Read SEC document |
| December 04, 2025 Filed Dec 4, 2025 21:11 UTC Amendment |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock $0.10 par value per share | 2,432 | $5.50 | $13,376.49 |
DisclosureSEC source: 0001437749-25-036913 · rdgdoc.xml · nonDerivative · entry 2 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,738 F2 · shares: This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date. Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 21:14 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock $0.10 par value per share | 3,521 | $5.04 | $17,747.95 |
DisclosureSEC source: 0001437749-25-036794 · rdgdoc.xml · nonDerivative · entry 3 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,785 Read SEC document |
| December 03, 2025 Filed Dec 3, 2025 21:14 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock $0.10 par value per share | 2,556 | $5.00 | $12,787.67 |
DisclosureSEC source: 0001437749-25-036794 · rdgdoc.xml · nonDerivative · entry 2 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,264 Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 21:11 UTC Amendment |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock $0.10 par value per share | 3,598 | $5.05 | $18,151.91 |
DisclosureSEC source: 0001437749-25-036913 · rdgdoc.xml · nonDerivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,306 F1 · shares: This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:14 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
PurchaseCommon Stock $0.10 par value per share | 3,708 | $4.87 | $18,052.77 |
DisclosureSEC source: 0001437749-25-036794 · rdgdoc.xml · nonDerivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,708 Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 13:12 UTC |
Tomsche David ScottDirector
|
PurchaseCommon Stock $0.10 par value per share | 1,633 | $4.77 | $7,781.25 |
DisclosureSEC source: 0001437749-25-036477 · rdgdoc.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,740 Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 13:12 UTC |
Tomsche David ScottDirector
|
PurchaseCommon Stock $0.10 par value per share | 1,633 | $4.76 | $7,773.08 |
DisclosureSEC source: 0001437749-25-036477 · rdgdoc.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,720 Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 13:43 UTC |
te Boekhorst Paul Francis OlivierDirector · President and CEO
|
GrantStock Options (right to buy) · Derivative | 74,277 | $6.10 Strike: $6.10 | $453,089.70 |
DisclosureSEC source: 0001437749-25-034257 · rdgdoc.xml · derivative · entry 1 te Boekhorst Paul Francis Olivier · CIK 0002095704 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,260 Underlying: Common Stock · 74,277 shares Expires 2035-11-07 F1 · derivative.exercise_date: Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 21:09 UTC |
Gathagan Bryan K.Director
|
PurchaseCommon stock $0.10 per value per share | 1,000 | $6.32 | $6,320.00 |
DisclosureSEC source: 0001213900-25-053904 · marketforms-69920.xml · nonDerivative · entry 1 Gathagan Bryan K. · CIK 0001981919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 17:05 UTC |
Basse Gloria FDirector
|
Exercise / conversionNon Qualified Stock Options (Right to buy) · Derivative | 3.53 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001213900-25-054188 · marketforms-69921.xml · derivative · entry 3 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,530 shares Expires 2025-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: (2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 17:05 UTC |
Basse Gloria FDirector
|
Exercise / conversionNon Qualified Stock Options (Right to buy) · Derivative | 11,470 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001213900-25-054188 · marketforms-69921.xml · derivative · entry 2 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,530 Underlying: Common Stock · 11,470 shares Expires 2025-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: (2) Original stock option was for 15,000 shares. These shares resulted from a net exercise transaction, with 11,470 shares withheld (credited at $6.29 per share, the closing price of the Common stock on the date of exercise) in payment of the exercise price for 3,530 shares. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 17:05 UTC |
Basse Gloria FDirector
|
Exercise / conversionCommon stock $0.10 per value per share | 3,530 | $4.81 | $16,979.30 |
DisclosureSEC source: 0001213900-25-054188 · marketforms-69921.xml · nonDerivative · entry 1 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: (1) Shares acquired in stock option net exercise transaction with the Issuer. Read SEC document |
| April 16, 2025 Filed Apr 23, 2025 16:53 UTC |
Fiori Timothy CChief Financial Officer
|
GrantIncentive Stock Options (Right to buy) · Derivative | 30,000 | $5.49 Strike: $5.49 | $164,700.00 |
DisclosureSEC source: 0001213900-25-034500 · marketforms-69199.xml · derivative · entry 1 Fiori Timothy C · CIK 0002063933 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:40 UTC |
Gathagan Bryan K.Director
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012240 · rdgdoc.xml · derivative · entry 1 Gathagan Bryan K. · CIK 0001981919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:39 UTC |
Wainman Paul RDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012238 · rdgdoc.xml · derivative · entry 1 Wainman Paul R · CIK 0001603581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:38 UTC |
Tomsche David ScottDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012236 · rdgdoc.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:37 UTC |
Brockmann Bobbi JoDirector · VP of Sales and Marketing
|
GrantIncentive Stock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012234 · rdgdoc.xml · derivative · entry 1 Brockmann Bobbi Jo · CIK 0001517536 · Director · VP of Sales and Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:36 UTC |
Rosgen Steven T.Director
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012232 · rdgdoc.xml · derivative · entry 1 Rosgen Steven T. · CIK 0001729885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:34 UTC |
Basse Gloria FDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012230 · rdgdoc.xml · derivative · entry 1 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:31 UTC |
Wainman Paul RDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081210 · marketforms-67039.xml · derivative · entry 1 Wainman Paul R · CIK 0001603581 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:30 UTC |
Basse Gloria FDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081209 · marketforms-67040.xml · derivative · entry 1 Basse Gloria F · CIK 0001869527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:30 UTC |
Tomsche David ScottDirector
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081207 · marketforms-67041.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:29 UTC |
Gathagan Bryan K.Director
|
GrantNon-Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081206 · marketforms-67042.xml · derivative · entry 1 Gathagan Bryan K. · CIK 0001981919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:29 UTC |
Rosgen Steven T.Director
|
GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081205 · marketforms-67043.xml · derivative · entry 1 Rosgen Steven T. · CIK 0001729885 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 16:25 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 2,186 | $3.55 | $7,760.30 |
DisclosureSEC source: 0001213900-24-074326 · marketforms-66862.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,797 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 19:00 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 6,005 | $3.55 | $21,317.75 |
DisclosureSEC source: 0001213900-24-072552 · marketforms-66848.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,611 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 17:05 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 10,000 | $3.55 | $35,500.00 |
DisclosureSEC source: 0001213900-24-071759 · marketforms-66833.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,606 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 19, 2024 Filed Aug 19, 2024 17:04 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 3,172 | $3.67 | $11,641.24 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 3 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,606 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 17:04 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 4,811 | $3.72 | $17,882.97 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,434 Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 17:04 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 2,017 | $3.57 | $7,194.64 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,623 Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 16:25 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon stock $0.10 per value per share | 3,100 | $4.75 | $14,737.71 |
DisclosureSEC source: 0001213900-23-074246 · marketforms-62560.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,606 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| June 28, 2023 Filed Aug 30, 2023 18:49 UTC |
Gathagan Bryan K.Director
|
GrantNon-Qualified Stock Options (Right to buy) · Derivative | 15,000 | $5.11 Strike: $5.11 | $76,650.00 |
DisclosureSEC source: 0001213900-23-072079 · marketforms-62425.xml · derivative · entry 1 Gathagan Bryan K. · CIK 0001981919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-06-28 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.44 | $544.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 25 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,506 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 24 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,406 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.53 | $553.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 23 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,337 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 22 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,237 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 21 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,168 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC |
Tomsche David ScottDirector
|
Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 20 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,137 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.